Back to Browse Journals

Clinical Pharmacology: Advances and Applications

Dr Frankel

Department of Hematology/Oncology, SouthWestern Medical Center, United States

Dr Frankel

Editor-in-Chief:  Professor Arthur E. Frankel

Dr. Arthur Frankel is a Professor at the Department of Internal Medicine, Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center.

Dr. Frankel earned his MD from Harvard Medical School and conducted his Medicine Internship at Yale University. Soon after completing his degree, Dr. Frankel began as a Research Scientist with the National Institute of Health and later completed his Medicine Residency and Oncology Fellowship at Stanford University. He is Board Certified in Internal Medicine, Medical Oncology and Hematology. Dr. Frankel is a member of the American Society of Clinical Oncology, American Society of Hematology and American Association of Cancer Research.

Dr. Frankel's main focus is combining the clinical practice of hematology/oncology with an investigative cancer drug development program to better move targeted cancer therapeutics into the clinical setting. He has participated in the development of targeted peptide toxins also called immunotoxins for melanoma, breast cancer, ovarian cancer, leukemia, lymphoma, chronic pain, prostate cancer, and thyroid cancer. He has performed phase I clinical trials for many of these agents. He has over 190 peer-reviewed articles, has edited three books, organized for international symposia and received grants from the American Cancer Society, the Leukemia and Lymphoma Society, NIH and the Van Andel Foundation.


Honorary Editorial Board

Rajesh Agarwal, Professor, Department of Pharmaceutical Sciences, School of Pharmacy, University of Colorado Health Sciences Center, Denver, CO, USA

Mustafa al'Absi, Professor, Max and Mary LaDue Pickworth Chair, Director, Duluth Medical Research Institute (DMRI), University of Minnesota Medical School, Duluth, MN, USA

Alejandro C. Arroliga, Professor and Interim Chairman, Department of Medicine, Scott and White Hospital, Texas A&M Health Science Center, College of Medicine, Temple, TX, USA

Julio C. Barredo, Director, Division of Pediatric Hematology-Oncology and Children’s Cancer Program, Toppel Family Professor of Pediatric Hematology-Oncology, University of Miami Miller School of Medicine, Miami, South Florida, USA

Kirby I. Bland, Fay Fletcher Kerner Professor and Chairman, Department of Surgery, University of Alabama at Birmingham School of Medicine, Birmingham, AL, USA

Jeffrey L. Blumer, Professor of Pediatrics and Pharmacology, Case Western Reserve University, School of Medicine, Cleveland, Ohio, USA

Kathleen T. Brady, Professor of Psychiatry, Department of Psychiatry and Behavioral Sciences, Clinical Neuroscience Division, Medical University of South Carolina, Charleston, SC, USA

Bridget Brosnihan, Professor, Department of Physiology & Pharmacology, Department of Neuroscience, Wake Forest University School of Medicine, Winston-Salem, NC, USA

Kim L. R. Brouwer, William R. Kenan, Jr., Distinguished Professor and Chair, Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA

Edmund V. Capparelli, Clinical Professor and Director, Pediatric Pharmacology Research Unit, University of California, San Diego, CA, USA

William C. Cho, Ph.D., Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong

James M. Cook, University Distinguished Professor, Organic Chemistry, Department of Chemistry and Biochemistry, University of Wisconsin-Milwaukee, Milwaukee, WI, USA

Steven M. Dubinett, Professor of Medicine and Pathology, Chief, Division of Pulmonary and Critical Care Medicine; Director, UCLA Lung Cancer Research Program, Jonsson Comprehensive Cancer Center, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA, USA

Nicholas S. Duesbery, Deputy Director for Research Operations and Senior Scientific Investigator of the Laboratory of Cancer and Developmental Cell Biology, Van Andel Institute, Grand Rapids, MI, USA

Nae J. Dun, Professor and Chairman, Department of Pharmacology, Temple University School of Medicine, Philadelphia, PA, USA

M. Elizabeth Fini, Director, Institute for Genetic Medicine, Professor of Cell and Neurobiology, Keck School of Medicine of USC, University of Southern California, Los Angeles, CA, USA

Joseph A. Fontana, Professor of Internal Medicine and Oncology, Karmanos Cancer Institite and Wayne State University, Chief of Hematology and Medical Oncology, John D. Dingell VA Medical Center, Detroit, Michigan, USA

William R. Freeman, Professor of Ophthalmology, Director Joan and Irwin Jacobs Retina Center, School of Medicine, University of California San Diego, La Jolla, USA

Laura J. Frishman, Professor of Optometry, Vision Science and Biology, Moores Professor, Associate Dean, College of Optometry, University of Houston, Calhoun, Houston, TX, USA

Hendrik Fuchs, Professor for Target Cell Directed Tumor Therapy, Head of the Laboratory of Molecular Tumor Therapy and Deputy Director of the Central Department of Laboratory Medicine and Pathobiochemistry, Charité - Universitätsmedizin Berlin, Germany

Ramesh Ganju, Scott Endowed Professor of Pathology, Vice-Chair Experimental Pathology, Ohio State University, Columbus, OH, USA

Juri G. Gelovani, Professor and Chairman, Department of Experimental Diagnostic Imaging, Director, Center for Advanced Biomedical Imaging Research, UT MD Anderson Cancer Center, Houston, TX, USA

Daniel Gillet, Chief of the Laboratory of Molecular Toxinology and Biotechnology, Section of Molecular Engineering of Proteins, Institute of Biology and Technologies of Saclay, Life Sciences Division, CEA, France

Leo Gordon, Professor, Division of Hematology/Oncology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA

Donna Hogge, Terry Fox Laboratory, BC Cancer Agency, Vancouver, BC, Canada

Naijie Jing, Department of Medicine, Section of Infectious Diseases, Baylor College of Medicine, Houston, TX, USA

Paul L Kaufman, Ernst H. Bárány Professor of Ocular Pharmacology, Department Chair Emeritus, Department of Ophthalmology and Visual Sciences, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA

Robert J. Kreitman, Chief, Clinical Immunotherapy Section, Laboratory of Molecular Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA

Macus Tien Kuo, Felix Haas Professor, Department of Translational Molecular Pathology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA

Terry C. Lairmore, Professor of Surgery, Director, Division of Surgical Oncology, Vice Chairman for Research, Scott and White Memorial Hospital and Clinic, Texas A&M University System Health Sciences Center, College of Medicine, Temple, TX, USA

Douglas A. Lappi, President and Chief Scientific Officer, Advanced Targeting Systems, San Diego, CA, USA

Charles Q Liu, Principal Scientist, Bioanalysis US Pharmacodynamics, Drug Discovery Research, Astellas Pharma Global Development, Skokie, IL, USA

Edythe D. London, Katherine K. and Thomas P. Pike Professor of Addiction Studies, Professor of Psychiatry, and Professor of Pharmacology, David Geffen School of Medicine, UCLA, Los Angeles, USA

Craig Malbon, Leading Professor and Director, DMDRC, State University of New York, Stony Brook, NY, USA

Craig J. McClain, Professor of Medicine, Department of Medicine, Division of Gastroenterology/Hepatology, University of Louisville School of Medicine and Louisville VAMC, Louisville, KY, USA

Lucio Miele, Ergon Professor of Medicine and Pharmacology, Director, University of Mississippi Cancer Institute, University of Mississippi Medical Center Cancer Institute, Jackson, MS, USA

William G. North, Professor of Physiology, Dartmouth Medical School, Hanover, NH, USA

Hui-Lin Pan, Helen T. Hawkins Distinguished Professor and Deputy Division Head for Research, Department of Anesthesiology and Perioperative Medicine, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA

Gavril W. Pasternak, Anne Burnett Tandy Chair in Neurology,Memorial Sloan-Kettering Cancer Center, Professor of Neurology and Neuroscience, Pharmacology and Psychiatry, Weill College of Medicine of Cornell University, Manhattan, New York City, NY, USA

Steven Piantadosi, Director, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA

Bruce G. Pollock, Professor of Psychiatry & Pharmacology, and Director, Division of Geriatric Psychiatry, University of Toronto, Faculty of Medicine, Vice President Research and Director, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Canada

Gregory H. Reaman, Adjunct Professor of Oncology and Pediatrics, Georgetown University School of Medicine, Executive Director for Scientific and Medical Affairs, National Childhood Cancer Foundation, Bethesda, Maryland, USA

Eva E. Redei, Ph.D., David Lawrence Stein Professor of Psychiatry, Department of Psychiatry and Behavioral Sciences, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA

Scot C. Remick, Director and Professor of Medicine, The Laurence and Jean DeLynn Chair of Oncology, Mary Babb Randolph Cancer Center, West Virginia University, Morgantown, WV, USA

Stephen H. Safe, Distinguished Professor, Department of Veterinary Physiology and Pharmacology, Director, Center for Environmental and Genetic Medicine, Institute of Biosciences and Technology, Texas A&M University and Health Science Center, College Station, TX, USA

Alan C Sartorelli, Alfred Gilman Professor of Pharmacology, Yale University School of Medicine, New Haven, CT, USA

J. Philip Saul, Professor of Pediatrics, Medical University of South Carolina, Charleston, SC, USA

David A. Scheinberg, Professor of Medicine and Pharmacology, Weill-Cornell University Medicial College, Vincent Astor Chair and Chairman, Molecular Pharmacology and Chemistry Program, Sloan-Kettering Institute, New York, NY, USA

Alan D. Stiles, Brewer Distinguished Professor and Chair, Department of Pediatrics, Physician-in-Chief, NC Children's Hospital, University of North Carolina, Chapel Hill, NC, USA

Giles Tamagnan, Director, Laboratory Research and Development, Molecular Neurolmaging LLC and Institute for Neurodegenerative Disorders, Associate Professor, Yale School of Medicine, New Haven, CT, USA

Daniel A. Vallera, Professor of Therapeutic Radiology - Radiation Oncology, Lion Scholar and Director, Section on Molecular Cancer Therapeutics, University of Minnesota Cancer Center, Minnesota, USA

John van den Anker, Professor, Children's National Medical Center, Washington, D.C., USA

Yu-Jui Yvonne Wan, Professor of Pharmacology, Toxicology and Therapeutics Joy McCann Professor Director, The Liver Center, The University of Kansas Medical Center, Kansas City, Kansas, USA

Donna Wang, Distinguished Professor, Chief, Division of Nanomedicine and Molecular Intervention, Michigan State University, East Lansing, Michigan, USA

Mariusz Wasik, Professor, Director of Experimental Hematology, Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA

David J. Waxman, Professor of Cell and Molecular Biology and Professor of Medicine, Boston University, Boston, Massachusetts, USA

Katherine Wisner, Professor of Psychiatry, Obstetrics, Gynecology and Reproductive Sciences, Epidemiology and Women's Studies, Director, Women's Behavioral HealthCARE, Western Psychiatric Institute and Clinic, University of Pittsburgh School of Medicine, Pittsburgh, USA

Ma-Li Wong, Miller Professor, Vice Chair for Translational Research, Director, Center on Pharmacogenomics, Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL, USA

Jung Hee Woo, Associate Director, Cancer Research Institute, Department of Internal Medicine, Scott and White Memorial Hospital, College of Medicine, Texas A&M University System Health Science Center, Temple, TX, USA